• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

极低出生体重儿中症状性动脉导管未闭的发病率及危险因素

Incidence and risk factors for symptomatic patent ductus arteriosus among inborn very-low-birth-weight infants.

作者信息

Furzan J A, Reisch J, Tyson J E, Laird P, Rosenfeld C R

出版信息

Early Hum Dev. 1985 Oct;12(1):39-48. doi: 10.1016/0378-3782(85)90135-5.

DOI:10.1016/0378-3782(85)90135-5
PMID:4064996
Abstract

The incidence of symptomatic patent ductus arteriosus (sPDA) in very-low-birth-weight infants has been reported almost exclusively from referral centers. Moreover, the incidence has varied considerably. We prospectively evaluated the incidence and risk factors of sPDA in a totally inborn population of infants less than or equal to 1500 g birth weight (n = 120) receiving conservative fluid management and examined the role of echocardiography in predicting sPDA before clinical signs are evident. The incidence of sPDA was relatively low (16%) and the age at onset was relatively late (mean +/- S.E. = 14.7 +/- 3.0 days) when compared to prior reports. Echocardiographic changes preceded physical and radiographic findings of sPDA. Fluid volume within the range administered to our infants was unrelated to the occurrence of sPDA. However, risk factors identifiable within 24 h of birth were defined: obstetric estimate of gestational age, race, mean fluid volume intake in the initial 24 h, and early treatment with volume expanders. From these risk factors, 79% of infants with sPDA and 79% without sPDA could be predicted by stepwise discriminant function analyses. These findings may be employed in studies needed to assess the benefit of early surgical or pharmacologic therapy for infants at highest risk for sPDA.

摘要

极低出生体重儿有症状动脉导管未闭(sPDA)的发病率几乎仅来自转诊中心的报告。此外,发病率差异很大。我们前瞻性评估了出生体重小于或等于1500g的完全自产婴儿(n = 120)中sPDA的发病率和危险因素,这些婴儿接受保守的液体管理,并在临床症状出现之前检查了超声心动图在预测sPDA中的作用。与先前的报告相比,sPDA的发病率相对较低(16%),发病年龄相对较晚(平均±标准误= 14.7±3.0天)。sPDA的超声心动图改变先于其体格检查和影像学表现。给予我们婴儿的液体量范围与sPDA的发生无关。然而,确定了出生后24小时内可识别的危险因素:产科估计的孕周、种族、最初24小时的平均液体摄入量以及早期使用扩容剂治疗。通过逐步判别函数分析,可从这些危险因素中预测79%有sPDA的婴儿和79%无sPDA的婴儿。这些发现可用于评估早期手术或药物治疗对sPDA高危婴儿益处的研究中。

相似文献

1
Incidence and risk factors for symptomatic patent ductus arteriosus among inborn very-low-birth-weight infants.极低出生体重儿中症状性动脉导管未闭的发病率及危险因素
Early Hum Dev. 1985 Oct;12(1):39-48. doi: 10.1016/0378-3782(85)90135-5.
2
Symptomatic patent ductus arteriosus in very-low-birth-weight infants: 1987-1989.极低出生体重儿的有症状动脉导管未闭:1987 - 1989年
Early Hum Dev. 1991 Nov;27(1-2):65-77. doi: 10.1016/0378-3782(91)90028-2.
3
Very Low Birth Weight Monochorionic Diamniotic Twins as a Risk Factor for Symptomatic Patent Ductus Arteriosus.极低出生体重单绒毛膜双羊膜囊双胎作为有症状动脉导管未闭的一个危险因素
Neonatology. 2016;109(3):228-34. doi: 10.1159/000442968. Epub 2016 Feb 10.
4
The effects of indomethacin tocolysis on the postnatal response of the ductus arteriosus to indomethacin in extremely low birth weight infants.吲哚美辛抑制宫缩对极低出生体重儿动脉导管产后对吲哚美辛反应的影响。
J Perinatol. 2007 Jan;27(1):22-7. doi: 10.1038/sj.jp.7211612. Epub 2006 Oct 19.
5
[Value of amino-terminal pro-brain natriuretic peptide as a predictive marker of symptomatic patent ductus arteriosus in preterm infants].[氨基末端脑钠肽前体作为早产儿症状性动脉导管未闭预测标志物的价值]
Zhongguo Dang Dai Er Ke Za Zhi. 2015 Nov;17(11):1160-4.
6
Indomethacin prophylaxis or expectant treatment of patent ductus arteriosus in extremely low birth weight infants?吲哚美辛对极低出生体重儿动脉导管未闭的预防性治疗还是期待性治疗?
J Perinatol. 2007 Mar;27(3):158-63. doi: 10.1038/sj.jp.7211659. Epub 2007 Jan 25.
7
Pulsed Doppler measurement of left ventricular output as early predictor of symptomatic patent ductus arteriosus in very preterm infants.脉冲多普勒测量左心室输出量作为极早产儿有症状动脉导管未闭的早期预测指标。
Biol Neonate. 1989;56(3):121-8. doi: 10.1159/000243112.
8
Cerebral hemodynamic change and intraventricular hemorrhage in very low birth weight infants with patent ductus arteriosus.极低出生体重儿动脉导管未闭时的脑血流动力学变化及脑室内出血
Ultrasound Med Biol. 2005 Feb;31(2):197-202. doi: 10.1016/j.ultrasmedbio.2004.10.006.
9
Utility of rapid B-type natriuretic peptide assay for diagnosis of symptomatic patent ductus arteriosus in preterm infants.快速B型利钠肽检测在早产儿有症状动脉导管未闭诊断中的应用
Pediatrics. 2005 Mar;115(3):e255-61. doi: 10.1542/peds.2004-1837. Epub 2005 Feb 1.
10
Association between early echocardiography, therapy for patent ductus arteriosus, and outcomes in very low birth weight infants.早期超声心动图、动脉导管未闭治疗与极低出生体重儿预后之间的关联
Cardiol Young. 2017 Nov;27(9):1732-1739. doi: 10.1017/S1047951117001081. Epub 2017 Jun 19.

引用本文的文献

1
Machine learning-based tool to assess risk of hemodynamically significant PDA in extremely premature infants.基于机器学习的工具,用于评估极早产儿血流动力学显著动脉导管未闭的风险。
Pediatr Res. 2025 Oct 29. doi: 10.1038/s41390-025-04489-w.
2
Sex Differences in Patent Ductus Arteriosus Incidence and Response to Pharmacological Treatment in Preterm Infants: A Systematic Review, Meta-Analysis and Meta-Regression.早产儿动脉导管未闭发病率及药物治疗反应的性别差异:一项系统评价、荟萃分析和元回归分析
J Pers Med. 2022 Jul 14;12(7):1143. doi: 10.3390/jpm12071143.
3
Comparative effectiveness of drugs used to constrict the patent ductus arteriosus: a secondary analysis of the PDA-TOLERATE trial (NCT01958320).
用于缩窄动脉导管未闭的药物的疗效比较:PDA-TOLERATE 试验的二次分析(NCT01958320)。
J Perinatol. 2019 May;39(5):599-607. doi: 10.1038/s41372-019-0347-4. Epub 2019 Mar 8.
4
Application of NPE in the assessment of a patent ductus arteriosus.应用 NPE 评估动脉导管未闭。
Pediatr Res. 2018 Jul;84(Suppl 1):46-56. doi: 10.1038/s41390-018-0077-x.
5
Functional Neonatal Echocardiography: Indian Experience.功能性新生儿超声心动图:印度经验
J Clin Diagn Res. 2015 Dec;9(12):SC11-4. doi: 10.7860/JCDR/2015/14440.6971. Epub 2015 Dec 1.
6
Effects of Advancing Gestation and Non-Caucasian Race on Ductus Arteriosus Gene Expression.孕周进展和非白种人种族对动脉导管基因表达的影响。
J Pediatr. 2015 Nov;167(5):1033-41.e2. doi: 10.1016/j.jpeds.2015.07.011. Epub 2015 Aug 8.
7
Patent ductus arteriosus in premature neonates.早产儿动脉导管未闭。
Drugs. 2012 May 7;72(7):907-16. doi: 10.2165/11632870-000000000-00000.
8
Patent ductus arteriosus: are current neonatal treatment options better or worse than no treatment at all?动脉导管未闭:当前新生儿的治疗选择是否优于完全不治疗?
Semin Perinatol. 2012 Apr;36(2):123-9. doi: 10.1053/j.semperi.2011.09.022.
9
Inadvertent relaxation of the ductus arteriosus by pharmacologic agents that are commonly used in the neonatal period.在新生儿期常用的药物作用下,动脉导管会不经意间松弛。
Semin Perinatol. 2010 Jun;34(3):222-30. doi: 10.1053/j.semperi.2010.02.007.
10
Variation in the diagnosis and management of patent ductus arteriosus in premature infants.早产儿动脉导管未闭诊断与管理的差异
Paediatr Child Health. 1998 Nov;3(6):405-10. doi: 10.1093/pch/3.6.405.